We have merged with Bristol Myers Squibb creating a leading biopharma company, ideally positioned to discover, develop and deliver innovative medicines for patients fighting serious diseases. Visit www.bms.com to learn more about our work to produce the next generation of medicines to treat cancer and other serious diseases.
For more information on the acquisition, see our press release at: http://bit.ly/3UbQcnl
Company Details
- Employees
- 106
- Address
- 400 Dexter Ave N., Seattle,wa 98109,united States
- Phone
- +1 206-696-0703
- In****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- junotherapeutics.com
- Keywords
- Biotechnology, Immunotherapy, cell therapy.
- HQ
- Seattle, WA
Juno Therapeutics, Inc. Questions
Juno Therapeutics, Inc.'s helpline number is +1 206-696-0703
Juno Therapeutics, Inc.'s website is junotherapeutics.com
Juno Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/juno-therapeutics
Juno Therapeutics, Inc. has
106 employees.
View email and phone details for 106
employees at Juno Therapeutics, Inc..
Juno Therapeutics, Inc.'s industry is
Biotechnology Research
Juno Therapeutics, Inc.'s top competitors are
Mirati Therapeutics,
Celgene,
Lyell Immunopharma,
Karuna Therapeutics,
Turning Point Therapeutics,
Myokardia,
Tq Therapeutics,
Pfizer,
Sana Biotechnology, Inc.,
Bristol Myers Squibb.
Juno Therapeutics, Inc.'s support email address is Info@junotherapeutics.com
Juno Therapeutics, Inc.'s categories are Biotechnology Research
